A carregar...

Survival Differences between Adolescent / Young Adults and Children with B-Precursor Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation

Risk adapted therapy has been the cornerstone of treatment for pediatric B-precursor acute lymphoblastic leukemia (B-ALL). Recently, age (>13 years at diagnosis) has been identified as a very high-risk feature for chemotherapy treated pediatric B-ALL patients. Whether age at time of transplant is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burke, Michael J., Gossai, Nathan, Wagner, John E., Smith, Angela R., Bachanova, Veronika, Cao, Qing, MacMillan, Margaret L., Stefanski, Heather S., Weisdorf, Daniel J., Verneris, Michael R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3530019/
https://ncbi.nlm.nih.gov/pubmed/22960388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.08.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!